Trump’s proposed 200% tariffs on imported drugs risk pushing up U.S. prescription costs, squeezing generics, and deepening supply chain concerns.
Originally published by The Economic Times https://economictimes.indiatimes.com/markets
Trump’s proposed 200% tariffs on imported drugs risk pushing up U.S. prescription costs, squeezing generics, and deepening supply chain concerns.
Originally published by The Economic Times https://economictimes.indiatimes.com/markets